KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) FCF Margin (2016 - 2025)

Historic FCF Margin for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to 1.43%.

  • Evolent Health's FCF Margin fell 5600.0% to 1.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.34%, marking a year-over-year decrease of 77900.0%. This contributed to the annual value of 0.24% for FY2024, which is 60400.0% down from last year.
  • According to the latest figures from Q3 2025, Evolent Health's FCF Margin is 1.43%, which was down 5600.0% from 8.8% recorded in Q2 2025.
  • Evolent Health's 5-year FCF Margin high stood at 23.92% for Q4 2021, and its period low was 25.16% during Q1 2021.
  • Over the past 5 years, Evolent Health's median FCF Margin value was 0.07% (recorded in 2024), while the average stood at 0.23%.
  • Over the last 5 years, Evolent Health's FCF Margin had its largest YoY gain of 315100bps in 2021, and its largest YoY loss of -261300bps in 2021.
  • Quarter analysis of 5 years shows Evolent Health's FCF Margin stood at 23.92% in 2021, then tumbled by -73bps to 6.52% in 2022, then soared by 130bps to 14.99% in 2023, then plummeted by -133bps to 5.01% in 2024, then skyrocketed by 129bps to 1.43% in 2025.
  • Its FCF Margin stands at 1.43% for Q3 2025, versus 8.8% for Q2 2025 and 0.83% for Q1 2025.